Tryptamine Therapeutics Appoints New Auditor; Shares Fall 7%

MT Newswires Live
06 Jan

Tryptamine Therapeutics (ASX:TYP) appointed BDO Audi as auditor, effective immediately, according to a Monday filing with the Australian bourse.

The appointment follows the resignation of the company's former auditor William Buck Audit and the board's decision to choose an auditor registered with the Canadian Accounting Board, the filing said.

Shares of the company fell past 7% in recent Monday trade.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10